| Primary |
| General Anaesthesia |
25.0% |
| Surgery |
14.0% |
| Anaesthesia |
12.5% |
| Induction Of Anaesthesia |
8.8% |
| Neuromuscular Blocking Therapy |
5.9% |
| Product Used For Unknown Indication |
5.9% |
| Drug Use For Unknown Indication |
5.1% |
| Wrong Drug Administered |
5.1% |
| Epilepsy |
2.9% |
| Maintenance Of Anaesthesia |
2.2% |
| Muscle Relaxant Therapy |
2.2% |
| Paralysis |
2.2% |
| Choledocholithotomy |
1.5% |
| Intubation |
1.5% |
| Premedication |
1.5% |
| Acute Myeloid Leukaemia |
0.7% |
| Appendicitis |
0.7% |
| Corneal Reflex Decreased |
0.7% |
| Diagnostic Procedure |
0.7% |
| Infection Prophylaxis |
0.7% |
|
| Wrong Drug Administered |
30.4% |
| Supraventricular Tachycardia |
13.0% |
| Respiratory Arrest |
8.7% |
| Anaphylactic Reaction |
6.5% |
| Circulatory Collapse |
6.5% |
| White Blood Cell Count Increased |
4.3% |
| Anaphylactoid Shock |
2.2% |
| Angioedema |
2.2% |
| Diplopia |
2.2% |
| Drug Effect Decreased |
2.2% |
| Drug Hypersensitivity |
2.2% |
| Drug Ineffective |
2.2% |
| Drug Interaction |
2.2% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.2% |
| Erythema |
2.2% |
| Hypersensitivity |
2.2% |
| Liver Function Test Abnormal |
2.2% |
| Mastocytosis |
2.2% |
| Muscle Spasms |
2.2% |
| Myocarditis |
2.2% |
|
| Secondary |
| Anaesthesia |
17.5% |
| Acute Myeloid Leukaemia |
15.3% |
| Drug Use For Unknown Indication |
14.0% |
| Product Used For Unknown Indication |
9.6% |
| General Anaesthesia |
7.2% |
| Induction Of Anaesthesia |
4.4% |
| Infection |
4.1% |
| Analgesic Therapy |
3.8% |
| Myelodysplastic Syndrome |
3.8% |
| Maternal Exposure Timing Unspecified |
3.7% |
| Scoliosis Surgery |
3.1% |
| Acute Promyelocytic Leukaemia |
2.2% |
| Sensory Disturbance |
1.9% |
| Antiemetic Supportive Care |
1.6% |
| Maintenance Of Anaesthesia |
1.6% |
| Sedation |
1.6% |
| Vascular Operation |
1.5% |
| Prophylaxis |
1.3% |
| Endotracheal Intubation |
0.9% |
| Neuromuscular Blockade |
0.9% |
|
| Gamma-glutamyltransferase Increased |
13.6% |
| Overdose |
7.8% |
| Anaphylactic Reaction |
5.8% |
| Neutropenia |
5.8% |
| Pneumonia |
5.8% |
| Rhabdomyolysis |
5.8% |
| Anaphylactic Shock |
4.9% |
| Cardiac Arrest |
4.9% |
| Hypotension |
4.9% |
| Respiratory Distress |
4.9% |
| Sepsis |
4.9% |
| Bronchospasm |
3.9% |
| Pancytopenia |
3.9% |
| Renal Failure |
3.9% |
| Respiratory Failure |
3.9% |
| Ventricular Tachycardia |
3.9% |
| Alanine Aminotransferase Increased |
2.9% |
| Conversion Disorder |
2.9% |
| Drug Effect Prolonged |
2.9% |
| Oropharyngeal Blistering |
2.9% |
|
| Concomitant |
| Anaesthesia |
19.7% |
| Induction Of Anaesthesia |
14.2% |
| Product Used For Unknown Indication |
8.7% |
| Maintenance Of Anaesthesia |
7.9% |
| Drug Use For Unknown Indication |
6.9% |
| Prophylaxis |
6.5% |
| Procedural Pain |
4.7% |
| Acute Myeloid Leukaemia |
4.1% |
| Premedication |
3.9% |
| Sedation |
3.9% |
| Acute Promyelocytic Leukaemia |
2.4% |
| Anti-infective Therapy |
2.4% |
| Renal Transplant |
2.4% |
| Depression |
2.2% |
| Endotracheal Intubation |
2.2% |
| Hypertension |
2.2% |
| Induction And Maintenance Of Anaesthesia |
1.6% |
| Intubation |
1.6% |
| Blood Pressure |
1.4% |
| Postoperative Analgesia |
1.4% |
|
| Hypotension |
9.5% |
| Serotonin Syndrome |
9.5% |
| Sepsis |
8.1% |
| Vomiting |
8.1% |
| Rhabdomyolysis |
6.8% |
| Sedation |
6.8% |
| Abdominal Sepsis |
5.4% |
| Mean Arterial Pressure Decreased |
5.4% |
| Tremor |
5.4% |
| Infusion Related Reaction |
4.1% |
| Respiratory Failure |
4.1% |
| Thrombocytopenia |
4.1% |
| Vasodilatation |
4.1% |
| Blood Creatinine Increased |
2.7% |
| Hyperlipidaemia |
2.7% |
| Hypersensitivity |
2.7% |
| Loss Of Consciousness |
2.7% |
| Muscle Spasms |
2.7% |
| Overdose |
2.7% |
| Pulmonary Haemorrhage |
2.7% |
|
| Interacting |
| Anaesthesia |
62.5% |
| Product Used For Unknown Indication |
25.0% |
| Acute Myeloid Leukaemia |
12.5% |
|
|
